Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

An article titled, "Non-A/Non-B Hepatitis: A Review and Interim Report of an Ongoing Prospective Study", outlined the role of NANB of subsequent development of chronic liver disease.

  • Read more about An article titled, "Non-A/Non-B Hepatitis: A Review and Interim Report of an Ongoing Prospective Study", outlined the role of NANB of subsequent development of chronic liver disease.

Article in Gastroenterology titled, "Post-transfusion hepatitis: The role of hepatitis B antibody", outlined the role of NANB of subsequent development of chronic liver disease.

  • Read more about Article in Gastroenterology titled, "Post-transfusion hepatitis: The role of hepatitis B antibody", outlined the role of NANB of subsequent development of chronic liver disease.

An article in Gastroenterology titled, "Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion Hepatitis: Role of _-globulin prophylaxis in its prevention", outlined the role of NANB of subsequent development of chronic liver disease.

  • Read more about An article in Gastroenterology titled, "Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion Hepatitis: Role of _-globulin prophylaxis in its prevention", outlined the role of NANB of subsequent development of chronic liver disease.

An article in The Yale Journal of Biology and Medicine titled, "Non-A, Non-B Hepatitis", outlined the role of NANB of subsequent development of chronic liver disease.

  • Read more about An article in The Yale Journal of Biology and Medicine titled, "Non-A, Non-B Hepatitis", outlined the role of NANB of subsequent development of chronic liver disease.

An article in the The Lancet titled "Non-A Non-B Hepatitis Post Transfusion Hepatitis", contained data that pointed to NANBH being the cause of a substantial cases of post-transfusion hepatitis.

  • Read more about An article in the The Lancet titled "Non-A Non-B Hepatitis Post Transfusion Hepatitis", contained data that pointed to NANBH being the cause of a substantial cases of post-transfusion hepatitis.

In an article titled "Transfusion-associated hepatitis not due to viral hepatitis type A or B" it was recognised NANB hepatitis was the cause of many cases of post-transfusion hepatitis in comparison to other types.

  • Read more about In an article titled "Transfusion-associated hepatitis not due to viral hepatitis type A or B" it was recognised NANB hepatitis was the cause of many cases of post-transfusion hepatitis in comparison to other types.

An article titled "Non-A, Non-B Hepatitis Associated With Chronic Liver Disease in a Haemodialysis Unit" in The Lancet described NANB hepatitis as relating to "high frequency of persistent hepatic dysfunction".

  • Read more about An article titled "Non-A, Non-B Hepatitis Associated With Chronic Liver Disease in a Haemodialysis Unit" in The Lancet described NANB hepatitis as relating to "high frequency of persistent hepatic dysfunction".

In a letter from Dr Walford, it was emphasised that 90% of all post-transfusion hepatitis in the USA and elsewhere was caused by non-A, non-B hepatitis viruses. It was described as rapidly fatal.

  • Read more about In a letter from Dr Walford, it was emphasised that 90% of all post-transfusion hepatitis in the USA and elsewhere was caused by non-A, non-B hepatitis viruses. It was described as rapidly fatal.

An article titled "Percutaneous Liver Biopsy and Chronic Liver Disease in Haemophiliacs" was published in The Lancet. It asserted that the high incidence of chronic liver disease was related to concentrate replacement therapy.

  • Read more about An article titled "Percutaneous Liver Biopsy and Chronic Liver Disease in Haemophiliacs" was published in The Lancet. It asserted that the high incidence of chronic liver disease was related to concentrate replacement therapy.

Following an "Away Day" with MacFarlane Trust trustees, Peter Stevens reported the feedback from this to the Eileen Trust Board that financial need must be a prerequisite for any disbursement by a charity.

  • Read more about Following an "Away Day" with MacFarlane Trust trustees, Peter Stevens reported the feedback from this to the Eileen Trust Board that financial need must be a prerequisite for any disbursement by a charity.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 702
  • Page 703
  • Page 704
  • Page 705
  • Current page 706
  • Page 707
  • Page 708
  • Page 709
  • Page 710
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.